| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.9 |